MetaCap

Who Owns Bio-Rad Laboratories Stock?

NYSE: BIO.BHealthcareMedical DevicesUSD

365.080.00 (0.00%)

At close: Aug 20, 10:24 AM ET · Delayed 15 min

Ownership breakdown

Held by institutions
0.04%
Institutional holders
7
  • Institutions 0.0%
  • Insiders 98.2%
  • Public and other 1.7%

Who owns Bio-Rad Laboratories stock?

Institutional investors own about 0.0% of Bio-Rad Laboratories's shares, spread across 7 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 98.23% of BIO.B.

The largest institutional holders are Flow Traders U.S. LLC (0.02%), Morgan Stanley (0.01%) and Wells Fargo & Company (0.00%). Together, the top 5 institutions control 0.0% of shares outstanding. In their latest filings, 0 of the top 5 institutions increased their BIO.B positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of BIO.B

Bio-Rad Laboratories top institutional holders
InstitutionShares% HeldChange
Flow Traders U.S. LLC7600.02%-22.8%
Morgan Stanley7120.01%0.0%
Wells Fargo & Company1700.00%0.0%
Whittier Trust Company1600.00%0.0%
UBS Group AG130.00%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of BIO.B

Bio-Rad Laboratories top fund holders
FundShares% Held
Gabelli Global Small & Mid Cap Value Trust1500.00%

Frequently asked questions

Who is the largest shareholder of Bio-Rad Laboratories?

Flow Traders U.S. LLC is the largest institutional shareholder of BIO.B, owning 0.02% of shares outstanding (760 shares) as of its latest 13F filing.

What percentage of Bio-Rad Laboratories is owned by institutions?

Institutions own about 0.0% of BIO.B shares and 2.2% of the public float.

How much of Bio-Rad Laboratories do insiders own?

Insiders, such as officers and directors, own about 98.23% of BIO.B shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related